CVE-2021-45031: Mepsan Stawiz Usc++

High severity, CVSS 7.7. EPSS: 0.8% chance of exploitation in the next 30 days.

A vulnerability in MEPSAN's USC+ before version 3.0 has a weakness in login function which lets attackers to generate high privileged accounts passwords.

Affected products

• Mepsan Stawiz Usc++: before 3.0 (fixed in 3.0)

Published 2022-03-30. Last modified 2026-06-17.